A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO)
A discrete choice experiment to assess cancer patients' preferences for when and how to make treatment decisions
A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
A systematic review of decision aids for patients making a decision about treatment for early breast cancer
Do medical oncology patients and their support persons agree about end of life issues?
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study
- Zhou, Meirong, Wang, Shouman, Wang, Jianguo, Cao, Hong, Xu, Haifan, Dai, Bin, Tang, Peizhi, Qian, Liyuan, Zhao, Xi, Xiao, Jun, Zhou, Huaiying, Hu, Jinhui, Wan, Nengbin, Ding, Li, Tripodi, D, Zdenkowski, Nicholas, O'Keefe, TJ, Sanchez, AM, Chen, L, Zhang, P, Xu, F, Yuan, Songlin, Hu, Xiongqiang, Zhou, Wei, Qing, Bohua, Liu, Mingwen, Sun, Weihua, Fan, Peizhi
Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer
Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment
Oncology patients’ and oncology nurses’ views on palliative chemotherapy: a cross-sectional comparison
Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer
Are you sure you would like to clear your session, including search history and login status?